Infusion of calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in colorectal cancer: A systematic review and meta-analysis

European Journal of Cancer

Volumn 48, Issue 12, 2012, Pages 1791-1798

  Wu, Zhenjie ^a   Ouyang, Jun ^a   He, Zhenhua ^a   Zhang, Sen ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Calcium and magnesium; Colorectal cancer; Meta analysis; Neurotoxicity; Oxaliplatin

Indexed keywords

CALCIUM; MAGNESIUM; OXALIPLATIN;

COLORECTAL CANCER; CONFIDENCE INTERVAL; HUMAN; META ANALYSIS; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENSORY SYSTEM; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

EID: 84864124365     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.03.018     Document Type: Article

References (22)

1. A. de Gramont, A. Figer, and M. Seymour Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2000 2938 2947
2. T. Andre, C. Boni, and L. Mounedji-Boudiaf Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2004 2343 2351
3. T.J. Lehky, G.D. Leonard, R.H. Wilson, J.L. Grem, and M.K. Floeter Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy Muscle Nerve 29 2004 387 392
4. F. Grolleau, L. Gamelin, M. Boisdron-Celle, B. Lapied, M. Pelhate, and E. Gamelin A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels J Neurophysiol 85 2001 2293 2297
5. L. Gamelin, M. Boisdron-Celle, and R. Delva Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer Clin Cancer Res 10 2004 4055 4061
6. H.S. Hochster, A. Grothey, and B.H. Childs Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity J Clin Oncol 25 2007 4028 4029
7. Hochster HS, Shpilsky A, Grothey A, Childs BH. Effect of intravenous (IV) calcium and magnesium (Ca/Mg) versus placebo on response to FOLFOX + bevacizumab (BEV) in the CONcePT trial. J Clin Oncol, 2008 ASCO Annual Meeting Proceedings, 2008 [Abstract 280].
8. W.Y. Chay, S.H. Tan, and Y.L. Lo Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathy Asia Pac J Clin Oncol 6 2010 270 277
9. K. Ishibashi, N. Okada, T. Miyazaki, M. Sano, and H. Ishida Effect of calcium and magnesium on neurotoxicity and blood platinum concentrations in patients receiving mFOLFOX6 therapy: a prospective randomized study Int J Clin Oncol 15 2010 82 87
10. A. Grothey, D.A. Nikcevich, and J.A. Sloan Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7 J Clin Oncol 29 2011 421 427
11. S. Greenland Invited commentary: a critical look at some popular meta-analytic methods Am J Epidemiol 140 1994 290 296
12. J.D. Emerson, E. Burdick, D.C. Hoaglin, F. Mosteller, and T.C. Chalmers An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials Control Clin Trials 11 1990 339 352
13. P. Juni, A. Witschi, R. Bloch, and M. Egger The hazards of scoring the quality of clinical trials for meta-analysis JAMA 282 1999 1054 1060
14. O. Muto, H. Ando, and T. Ono Reduction of oxaliplatin-related neurotoxicity by calcium and magnesium infusions Gan To Kagaku Ryoho 34 2007 579 581
15. L. Gamelin, M. Boisdron-Celle, and A. Morel Oxaliplatin-related neurotoxicity: interest of calcium-magnesium infusion and no impact on its efficacy J Clin Oncol 26 2008 1188 1189
16. T. Kono, N. Mamiya, and N. Chisato Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer Evid Based Complement Altern Med 2009
17. M. Dong, P.Y. Xing, P. Liu, F.Y. Feng, and Y.K. Shi Assessment of the protective effect of calcium-magnesium infusion and glutathione on oxaliplatin-induced neurotoxicity Zhonghua Zhong Liu Za Zhi 32 2010 208 211
18. N. Knijn, J. Tol, and M. Koopman The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients Eur J Cancer 47 2011 369 374
19. A. Trotti, A.D. Colevas, and A. Setser CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181
20. K. Shirao, Y. Matsumura, and Y. Yamada Phase I study of single-dose oxaliplatin in Japanese patients with malignant tumors Jpn J Clin Oncol 36 2006 295 300
21. F. Levi, B. Perpoint, and C. Garufi Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate Eur J Cancer 29A 1993 1280 1284
22. G. Cavaletti, B. Frigeni, and F. Lanzani Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools Eur J Cancer 46 2010 479 494